Skip to content

Surgery Versus PhysiothErapist-leD Exercise for Traumatic Tears of the Rotator Cuff

Surgery Versus PhysiothErapist-leD Exercise for Traumatic Tears of the Rotator Cuff: a Multi-site Pilot and Feasibility Randomised Controlled Trial (the SPeEDy Study)

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04027205
Acronym
SPeEDy
Enrollment
0
Registered
2019-07-19
Start date
2020-03-03
Completion date
2021-02-03
Last updated
2021-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Rotator Cuff Tear

Brief summary

The SPeEDy study is a parallel group, pilot and feasibility randomised controlled trial (RCT) with integrated Quintet Recruitment Intervention (QRI) and further qualitative interviews. The study hypothesis is: In adult patients diagnosed with traumatic tears of the rotator cuff, is it feasible to conduct a future, substantive, multi-site RCT to test the hypothesis that physiotherapist-led exercise is not inferior to surgical repair of the rotator cuff in terms of clinical outcomes but is more cost-effective.

Detailed description

Tears of the rotator cuff are a significant cause of shoulder pain. Rates of surgical repair have risen approximately 200% over the last 20 years across Europe and the USA. 9 189 repairs were undertaken in 2015/ 2016 in the NHS. The cost of surgery ranges from £2 897 to £5 593 meaning that direct NHS treatment costs alone are £26.6 to £51.4 million annually. If a patient is suspected of having a traumatic rotator cuff tear, then guidance from the British Elbow and Shoulder Society and British Orthopaedic Association suggests this is a 'red flag' needing urgent surgical opinion. But, this guidance is open to question. Three randomised controlled trials (RCT) (n = 252) have been synthesised in a systematic review which concluded that surgery is not more effective than conservative care for rotator cuff tears. But, of the 252 patients included, only 40 (16%), were diagnosed with traumatic tears. Hence, there is a dearth of randomised evidence to inform decision-making. Given uncertainty about the comparative effectiveness of surgery and considering the cost, risk, for example infection, there is an urgent need to carry out high-quality research in this area. Research Question: In patients diagnosed with traumatic tears of the rotator cuff, is it feasible to conduct a future multicentre RCT to test the hypothesis that physiotherapist-led exercise is not inferior to surgical repair in terms of clinical outcomes but is more cost-effective. Research Design: Two-arm, parallel group, pilot and feasibility RCT with nested Quintet Recruitment Intervention (QRI) and qualitative interviews. Setting: Eight NHS hospitals. Objectives: 1. Determine feasibility of recruiting and retaining patients, 2. Identify barriers and facilitators to recruitment and retention, including patient and clinician equipoise and proportion and reasons for treatment cross-over (reflective of known challenges in surgical RCTs), 3. Estimate the number of potential and willing sites for the future main trial. Participants: Adults with traumatic tears of the rotator cuff, eligible for surgery. Intervention/ control: Participants will be allocated on a 1:1 ratio, stratified by tear size to: 1) Structured and progressive physiotherapist-led exercise; 2) Surgical repair and usual post-operative rehabilitation. Key feasibility outcomes: 1) Numbers of patients screened, eligible, approached, consenting, randomised, and accepting allocation; 2) Rate of retention and follow-up; 3) Feasibility of recruiting participating sites; 4) Participant satisfaction. Key clinical outcomes: 1) Shoulder pain and function (Oxford Shoulder Score): Quality of life (EQ-5D-5L) at baseline, three, and six months. Health economic outcomes: Health care resource use and days lost from work over six-months. Sample size: 76 participants. Analysis: Analysis will focus on process outcomes (recruitment, retention, and treatment cross-over). Means and confidence intervals of clinical outcomes will be calculated only to inform the sample size calculation for the future main trial. The QRI will use targeted methods including interviews with clinicians and patients, audio-recording of recruitment appointments and document review to understand and then develop an action plan to optimise recruitment and informed consent. Semi-structured qualitative interviews will explore treatment acceptability and the data will be analysed thematically.

Interventions

A programme of physiotherapist-led exercise over approximately 12 weeks.

Surgical repair of the rotator cuff plus usual post-operative rehabilitation

Sponsors

National Institute for Health Research, United Kingdom
CollaboratorOTHER_GOV
University Hospitals of Derby and Burton NHS Foundation Trust
CollaboratorOTHER
University Hospitals, Leicester
CollaboratorOTHER
Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust
CollaboratorOTHER_GOV
University Hospitals of North Midlands NHS Trust
CollaboratorOTHER
University Hospitals Coventry and Warwickshire NHS Trust
CollaboratorOTHER
Airedale NHS Foundation Trust
CollaboratorOTHER
Liverpool University Hospitals NHS Foundation Trust
CollaboratorOTHER_GOV
University Hospital Birmingham NHS Foundation Trust
CollaboratorOTHER
Keele University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adult patients (≥18 years) 2. Diagnosed with a symptomatic tear of the rotator cuff following a traumatic incident thought to be of sufficient force to induce a tear. 3. Rotator cuff tear confirmed by diagnostic ultrasound or MRI scan undertaken as part of routine diagnostic work-up 4. Eligible for rotator cuff repair surgery or a programme of physiotherapist-led exercise as determined by the attending clinician (surgeon or physiotherapist, where appropriate) 5. Able to return to the participating NHS hospital or associated orthopaedic and physiotherapy services (where physiotherapists have been trained in trial interventions) for post-operative rehabilitation or the programme of physiotherapist-led exercise. 6. Able to understand English.

Exclusion criteria

1. Not eligible for rotator cuff repair surgery or a programme of physiotherapist-led exercise as determined by the attending clinician (surgeon or physiotherapist, where appropriate) 2. Patients who are unable to give full informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Participant satisfaction with the interventions: five-point ordinal scaleSix monthsParticipant satisfaction with the interventions on a five-point ordinal scale; Very Satisfied/Satisfied/Neutral/Dissatisfied/Very Dissatisfied
Numbers of patients screened, number eligible, number approached, number consenting, number randomised, and number accepting allocationOver recruitment period, 15 monthsNumbers of patients screened, number eligible, number approached, number consenting, number randomised, and number accepting allocation will be recorded descriptively
Numbers of participants continuing in allocated treatmentSix monthsNumbers of participants continuing in allocated treatment will be recorded descriptively
Follow-up response rates to questionnaires (including Oxford Shoulder Score and EQ-5D-5L)Three months post-randomisationFollow-up response rates to questionnaires will be recorded descriptively
Determination of zone of clinical equipoiseOver recruitment period, 15 monthsData from screening logs, including reasons for not approaching potentially eligible patients will be recorded descriptively to inform determination of zone of clinical equipoise
Treatment cross-overSix monthsNumbers of participants receiving treatment (surgery or PT-led exercise) other than that which was allocated to determine proportion of participants who cross-over will be recorded descriptively

Secondary

MeasureTime frameDescription
Pain and disability assessed using the Oxford Shoulder Score (OSS)Three and six months post-randomisationThe OSS is a 12-item shoulder-specific self-report measure of shoulder pain and function primarily for the assessment of outcome of shoulder surgery in RCTs. The OSS is reliable, valid, responsive and acceptable to patients. The items refer to the past 4 weeks with five ordinal response options scored from 0 to 4, with 4 representing the best outcome. When the 12 items are summed, this produces an overall score ranging from 0 to 48, with 48 being the best outcome.
Health related quality of life assessed using the EQ-5D-5LThree and six months post-randomisationThe EQ-5D-5L is a generic measure of health related quality of life that provides a single index value for health status that can be used for the purpose of clinical and health economic evaluation. The EQ-5D-5L consists of questions relating to five health domains (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) and respondents rate their degree of impairment using five response levels (no problems, slight problems, moderate problems, severe problems and extreme problems). The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state. A total of 3125 possible health states can be defined in this way which can then be converted in to a single index value between 0 and 1,
Days lost from work due to the shoulder problemThree and six months post-randomisationDays lost from work due to the shoulder problem will be recorded descriptively on a self-report questionnaire
Time taken to return to drivingThree and six months post-randomisationTime taken to return to driving will be recorded descriptively on a self-report questionnaire

Other

MeasureTime frameDescription
Number of recruiting participating sites and numbers of additional sites who are interested in participating in the main trialWhole study period, 36 monthsNumber of recruiting participating sites and numbers of additional sites who are interested in participating in the main trial will be recorded descriptively
Number and type of adverse eventsUp to six months post-randomisationNumber and type of adverse events will be recorded descriptively following patient or clinician report

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026